EORTC New Drug Development Office coordinating and monitoring programme for phase I and II trials with new anticancer agents.
Schwartsmann
G
G
EORTC-NDDO, Free University Hospital, Amsterdam, The Netherlands.
Wanders
J
J
Koier
I J
IJ
Franklin
H R
HR
Dalesio
O
O
Hornstra
H W
HW
van Glabbeke
M
M
Renard
J
J
Van Oosterom
A T
AT
Kaye
S B
SB
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002985:Clinical Protocols; D002986:Clinical Trials as Topic; D015195:Drug Design; D004341:Drug Evaluation; D004992:Ethics, Medical; D005062:European Union; D006801:Humans; D007880:Legislation, Drug; D011358:Product Surveillance, Postmarketing
D000970:Antineoplastic Agents